Literature DB >> 15009805

Biochemical characterization of recombinant and circulating human Spalpha.

M R Sarrias1, O Padilla, Y Monreal, M Carrascal, J Abian, J Vives, J Yélamos, F Lozano.   

Abstract

Human Spalpha is a soluble protein expressed by macrophages present in lymphoid tissues (spleen, lymph node, thymus, and bone marrow), for which little functional and structural information is available. It belongs to the group B of the scavenger receptor cysteine-rich superfamily (SRCR-SF) that includes the lymphocyte surface receptors CD5 and CD6 among others. Spalpha is able to bind to different cells of the immune system (monocytes and lymphocytes), which suggests that it may play an important role in the regulation of this system. To study Spalpha, an episomal mammalian expression system (pCEP-Pu/HEK 293-EBNA) was used to produce a recombinant form (rSpalpha) that was utilized for biochemical studies and for the generation of specific hybridomas. Four monoclonal antibodies were selected for their reactivity against rSpalpha by Western blot, immunoprecipitation, and enzyme-linked immunosorbent assays. The monoclonal antibodies recognized three different epitopes on Spalpha. The monoclonal antibodies revealed the existence of two Spalpha isoforms of 38 and 40 kDa, resulting from different sialic acid content. They also showed that Spalpha is a relatively abundant serum protein (60 micro g/ml) that mostly circulates in association with other serum proteins. Accordingly, rSpalpha allowed affinity chromatography isolation of polyclonal and monoclonal immunoglobulin M (IgM). These data indicate that Spalpha is a circulating protein that may play a role in the homeostasis of IgM antibodies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009805     DOI: 10.1111/j.0001-2815.2004.00193.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  15 in total

1.  Activation of apoptosis inhibitor of macrophage is a sensitive diagnostic marker for NASH-associated hepatocellular carcinoma.

Authors:  Noriyuki Koyama; Tomoko Yamazaki; Yuka Kanetsuki; Jiro Hirota; Tomohide Asai; Yasuhide Mitsumoto; Masayuki Mizuno; Toshihide Shima; Yoshihiro Kanbara; Satoko Arai; Toru Miyazaki; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2017-10-30       Impact factor: 7.527

2.  The macrophage soluble receptor AIM/Api6/CD5L displays a broad pathogen recognition spectrum and is involved in early response to microbial aggression.

Authors:  Vanesa G Martinez; Cristina Escoda-Ferran; Inês Tadeu Simões; Satoko Arai; Marc Orta Mascaró; Esther Carreras; Mario Martínez-Florensa; José Yelamos; Toru Miyazaki; Francisco Lozano
Journal:  Cell Mol Immunol       Date:  2014-03-03       Impact factor: 11.530

3.  The Lymphocytic Scavenger Receptor CD5 Shows Therapeutic Potential in Mouse Models of Fungal Infection.

Authors:  María Velasco-de Andrés; Cristina Català; Sergi Casadó-Llombart; Mario Martínez-Florensa; Inês Simões; Joaquín García-Luna; Gustavo Mourglia-Ettlin; Óscar Zaragoza; Esther Carreras; Francisco Lozano
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

4.  Glycoproteomic analysis of plasma from patients with atopic dermatitis: CD5L and ApoE as potential biomarkers.

Authors:  Won Kon Kim; Hyang Ran Hwang; Do Hyung Kim; Phil Young Lee; Yu Jung In; Hye Young Ryu; Sung Goo Park; Kwang Hee Bae; Sang Chul Lee
Journal:  Exp Mol Med       Date:  2008-12-31       Impact factor: 8.718

5.  CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock.

Authors:  Maria-Rosa Sarrias; Montserrat Farnós; Rubén Mota; Fernando Sánchez-Barbero; Anna Ibáñez; Idoia Gimferrer; Jorge Vera; Rafael Fenutría; Cristina Casals; José Yélamos; Francisco Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-29       Impact factor: 11.205

6.  The human CD5L/AIM-CD36 axis: A novel autophagy inducer in macrophages that modulates inflammatory responses.

Authors:  Lucía Sanjurjo; Núria Amézaga; Gemma Aran; Mar Naranjo-Gómez; Lilibeth Arias; Carolina Armengol; Francesc E Borràs; Maria-Rosa Sarrias
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

7.  Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients.

Authors:  Lavanya Balakrishnan; Mitali Bhattacharjee; Sartaj Ahmad; Raja Sekhar Nirujogi; Santosh Renuse; Yashwanth Subbannayya; Arivusudar Marimuthu; Srinivas M Srikanth; Rajesh Raju; Mukesh Dhillon; Navjyot Kaur; Ramesh Jois; Vivek Vasudev; Yl Ramachandra; Nandini A Sahasrabuddhe; Ts Keshava Prasad; Sujatha Mohan; Harsha Gowda; Subramanian Shankar; Akhilesh Pandey
Journal:  Clin Proteomics       Date:  2014-01-06       Impact factor: 3.988

8.  Transgenic expression of soluble human CD5 enhances experimentally-induced autoimmune and anti-tumoral immune responses.

Authors:  Rafael Fenutría; Vanesa G Martinez; Inês Simões; Jorge Postigo; Victor Gil; Mario Martínez-Florensa; Jordi Sintes; Rodrigo Naves; Kevin S Cashman; José Alberola-Ila; Manel Ramos-Casals; Gloria Soldevila; Chander Raman; Jesús Merino; Ramón Merino; Pablo Engel; Francisco Lozano
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

9.  Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study.

Authors:  Jamal Sarvari; Zahra Mojtahedi; Seyed Ali Reza Taghavi; Yasuhiro Kuramitsu; Mahmoud Shamsi Shahrabadi; Abbas Ghaderi; Kazuyuki Nakamura
Journal:  Hepat Mon       Date:  2013-07-03       Impact factor: 0.660

10.  The scavenger protein apoptosis inhibitor of macrophages (AIM) potentiates the antimicrobial response against Mycobacterium tuberculosis by enhancing autophagy.

Authors:  Lucía Sanjurjo; Núria Amézaga; Cristina Vilaplana; Neus Cáceres; Elena Marzo; Marta Valeri; Pere-Joan Cardona; Maria-Rosa Sarrias
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.